Skip to main content
Brain Pathology logoLink to Brain Pathology
. 2006 Apr 5;13(2):223–228. doi: 10.1111/j.1750-3639.2003.tb00021.x

Peripheral Neuropathies in HIV‐infected Patients in the Era of HAART

François‐Jérôme Authier 1,, Romain K Gheradi 1
PMCID: PMC8095769  PMID: 12744475

Full Text

The Full Text of this article is available as a PDF (499.7 KB).

INSERM EI 0011, Faculté de Médecine de Créteil‐Paris XII, Créteil, France.

References

  • 1. Adle‐Biassette H, Bell JE, Creange A, Sazdovitch V, Authier FJ, Gray F, Hauw JJ, Gherardi R (1998) DNA breaks detected by in situ end‐labelling in dorsal root ganglia of patients with AIDS. Neuropathol Appl Neurobiol 24: 373–80. [DOI] [PubMed] [Google Scholar]
  • 2. Arnaudo E, Dalakas M, Shanske S, Moraes CT, DiMauro S, Schon EA (1991) Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine‐induced myopathy Lancet 337: 508–10. [DOI] [PubMed] [Google Scholar]
  • 3. Barohn RJ, Gronseth GS, LeForce BR, McVey AL, McGuire SA, Butzin CA, King RB (1993) Peripheral nervous system involvement in a large cohort of human immunodeficiency virus‐infected individuals. Arch Neurol 50: 167–71. [DOI] [PubMed] [Google Scholar]
  • 4. Benbrik E, Chariot P, Bonavaud S, Ammi‐Said M, Frisdal E, Rey C, Gherardi R, Barlovatz‐Meimon G (1997) Cellular and mitochondrial toxicity of zidovudine (AZT), didanosine (ddI) and zalcitabine (ddC) on cultured human muscle cells. J Neurol Sci 149:19–25. [DOI] [PubMed] [Google Scholar]
  • 5. Brinkman K, Smeitink JA, Romijn JA, Reiss P (1999) Mitochondrial toxicity induced by nucleoside‐analogue reverse‐transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral‐therapy‐related lipodystrophy. Lancet 354: 1112–5. [DOI] [PubMed] [Google Scholar]
  • 6. Carr A, Cooper DA (2000) Adverse effects of antiretroviral therapy. Lancet 356: 1423–30. [DOI] [PubMed] [Google Scholar]
  • 7. Chariot P, Monnet I, Gherardi R (1993) Cytochrome c oxidase reaction improves histopathological assessment of zidovudine myopathy. Ann Neurol 34: 561–5. [DOI] [PubMed] [Google Scholar]
  • 8. Chariot P, Monnet I, Mouchet M, Rohr M, Lefaucheur JP, Dubreuil‐Lemaire ML, Chousterman M, Gherardi R (1994) Determination of the blood lactate:pyruvate ratio as a noninvasive test for the diagnosis of zidovudine myopathy. Arthritis Rheum 37: 583–6. [DOI] [PubMed] [Google Scholar]
  • 9. Childs EA, Lyles RH, Selnes OA, Chen B, Miller EN, syndrome) which is Cohen BA, Becker JT, Mellors J, McArthur JC (1999) Plasma viral load and CD4 lymphocytes predict HIV‐associated dementia and sensory neuropathy. Neurology 1999 52: 607–13. [DOI] [PubMed] [Google Scholar]
  • 10. Constans J, Ladner J, Dabis F, Brossard G, Commenges D, Leng B, Conri C (1992) CD8 hyperlymphocytosis in HIV infection. 63 cases. GECSA (Groupe d'Epidemiologie Clinique du SIDA en Aquitaine). Presse Med 21: 27–30. [PubMed] [Google Scholar]
  • 11. Dalakas MC (2001) Peripheral neuropathy and antiretroviral drugs. J Peripher Nerv Syst 6:14–20. [DOI] [PubMed] [Google Scholar]
  • 12. Dalakas MC, Cupler EJ (1996) Neuropathies in HIV infection. Baillieres Clin Neurol 5: 199–218. [PubMed] [Google Scholar]
  • 13. Dalakas MC, Illa I, Pezeshkpour GH, Laukaitis JP, Cohen B, Griffin JL (1990) Mitochondrial myopathy caused by long‐term zidovudine therapy. N Engl J Med 322: 1098–105. [DOI] [PubMed] [Google Scholar]
  • 14. Dalakas MC, Semino‐Mora C, Leon‐Monzon M (2001) Mitochondrial alterations with mitochondrial DNA depletion in the nerves of AIDS patients with peripheral neuropathy induced by 2′3′ ‐dideoxycytidine (ddC). Lab Invest 81: 1537–44. [DOI] [PubMed] [Google Scholar]
  • 15. De la Monte SM, Gabuzda DH, Ho DD, Brown RH Jr, Hedley‐Whyte ET, Schooley RT, Hirsch MS, Bhan AK (1988) Peripheral neuropathy in the acquired immunode‐ficiency syndrome. Ann Neurol 23: 485–92. [DOI] [PubMed] [Google Scholar]
  • 16. Esiri MM, Morris CS, Millard PR (1993) Sensory and sympathetic ganglia in HIV‐1 infection: immunocytochemical demonstration of HIV‐1 viral antigens, increased MHC class II antigen expression and mild reactive inflammation. J Neurol Sci 114: 178–87. [DOI] [PubMed] [Google Scholar]
  • 17. Feldman D, Anderson TD (1994) Schwann cell mitochondrial alterations in peripheral nerves of rabbits treated with 2′,3′ ‐dideoxycytidine. Acta Neuropathol 87: 71–80. [DOI] [PubMed] [Google Scholar]
  • 18. Gherardi R, Belec L, Mhiri C, Gray F, Lescs MC, Sobel A, Guillevin L, Wechsler J (1993) The spectrum of vasculitis in human immunodeficiency virus‐infected patients. A clinicopathologic evaluation. Arthritis Rheum 36: 1164–74. [DOI] [PubMed] [Google Scholar]
  • 19. Gherardi R, Lebargy F, Gaulard P, Mhiri C, Bernaudin JF, Gray F (1989) Necrotizing vasculitis and HIV replication in peripheral nerves. N Engl J Med 321: 685–6. [DOI] [PubMed] [Google Scholar]
  • 20. Gherardi RK, Chretien F, Delfau‐Larue MH, Authier FJ, Moulignier A, Roulland‐Dussoix D, Belec L (1998) Neuropathy in diffuse infiltrative lymphocytosis syndrome: an HIV neuropathy, not a lymphoma. Neurology 50: 1041–4. [DOI] [PubMed] [Google Scholar]
  • 21. Itescu S, Brancato LJ, Buxbaum J, Gregersen PK, Rizk CC, Croxson TS, Solomon GE, Winchester R (1990) Adiffuse infiltrative CD8 lymphocytosis syndrome in human immunodeficiency virus (HIV) infection: a host immune response associated with HLA‐DR5. Ann Intern Med 112:3–10. [DOI] [PubMed] [Google Scholar]
  • 22. Itescu S, Dalton J, Zhang HZ, Winchester R (1993) Tissue infiltration in a CD8 lymphocytosis syndrome associated with human immunodeficiency virus‐1 infection has the phenotypic appearance of an antigenically driven response. J Clin Invest 91: 2216–25. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Jaffe ES (1984) Pathologic and clinical spectrum of post‐thymic T‐cell malignancies. Cancer Invest 2: 413–26. [DOI] [PubMed] [Google Scholar]
  • 24. Jubelt B, Berger JR (2001) Does viral disease underlie ALS? Lessons from the AIDS pandemic. Neurology 57:945–6. [DOI] [PubMed] [Google Scholar]
  • 25. Kolson DL, Gonzalez‐Scarano F (2001) HIV‐associated neuropathies: role of HIV‐1, CMV, and other viruses. J Peripher Nerv Syst 6: 2–7. [DOI] [PubMed] [Google Scholar]
  • 26. Lange DJ (1994) AAEM minimonograph $41: neuromuscular diseases associated with HIV‐1 infection. Muscle Nerve 17: 16–30. [DOI] [PubMed] [Google Scholar]
  • 27. Lefaucheur JP, Authier FJ, Verroust J, Gherardi RK (1997) Zidovudine and human immunodeficiency virus‐associated peripheral neuropathies: low intake in patients with mononeuropathy multiplex and no evidence for neurotoxicity. Muscle Nerve 20: 106–9. [PubMed] [Google Scholar]
  • 28. Lewis W, Dalakas MC (1995) Mitochondrial toxicity of antiviral drugs. Nat Med 1: 417–22. [DOI] [PubMed] [Google Scholar]
  • 29. MacGowan DJ, Scelsa SN, Waldron M (2001) An ALS‐like syndrome with new HIV infection and complete response to antiretroviral therapy. Neurology 57: 1094–7. [DOI] [PubMed] [Google Scholar]
  • 30. Markus R, Brew BJ (1998) HIV‐1 peripheral neuropathy and combination antiretroviral therapy. Lancet 352: 1906–7. [DOI] [PubMed] [Google Scholar]
  • 31. Maschke M, Kastrup O, Esser S, Ross B, Hengge U, Hufnagel A (2000) Incidence and prevalence of neurological disorders associated with HIV since the introduction of highly active antiretroviral therapy (HAART). J Neurol Neurosurg Psychiatry 69: 376–80. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. Mhiri C, Baudrimont M, Bonne G, Geny C, Degoul F, Marsac C, Roullet E, Gherardi R (1991) Zidovudine myopathy: a distinctive disorder associated with mitochondrial dysfunction. Ann Neurol 29:606–14. [DOI] [PubMed] [Google Scholar]
  • 33. Moulignier A, Authier FJ, Baudrimont M, Pialoux G, Belec L, Polivka M, Clair B, Gray F, Mikol J, Gherardi RK (1997) Peripheral neuropathy in human immunodeficiency virus‐infected patients with the diffuse infiltrative lymphocytosis syndrome. Ann Neurol 41:438–45. [DOI] [PubMed] [Google Scholar]
  • 34. Moulignier A, Moulonguet A, Pialoux G, Rozenbaum W (2001) Reversible ALS‐like disorder in HIV infection. Neurology 57: 995–1001. [DOI] [PubMed] [Google Scholar]
  • 35. Rizzuto N, Cavallaro T, Monaco S, Morbin M, Bonetti B, Ferrari S, Galiazzo‐Rizzuto S, Zanette G, Bertolasi L (1995) Role of HIV in the pathogenesis of distal symmetrical peripheral neuropathy. Acta Neuropathol 90: 244–50. [DOI] [PubMed] [Google Scholar]
  • 36. Said G, Lacroix C, Chemouilli P, Goulon‐Goeau C, Roullet E, Penaud D, de Broucker T, Meduri G, Vincent D, Torchet M, et al (1991) Cytomegalovirus neuropathy in acquired immunodeficiency syndrome: a clinical and pathological study. Ann Neurol 29: 139–46. [DOI] [PubMed] [Google Scholar]
  • 37. Schifitto G, McDermott MP, McArthur JC, Marder K, Sacktor N, Epstein L, Kieburtz K (2002) Incidence of and risk factors for HIV‐associated distal sensory polyneuropathy. Neurology 58: 1764–8. [DOI] [PubMed] [Google Scholar]
  • 38. Shapshak P, Nagano I, Xin K, Bradley W, McCoy CB, Sun NC, Stewart RV, Yoshioka M, Petito C, Goodkin K (1995) HIV‐1 heterogeneity and cytokines. Neuropathogenesis. Adv Exp Med Biol 373: 225–38. [DOI] [PubMed] [Google Scholar]
  • 39. Simpson DM, Wolfe DE (1991) Neuromuscular complications of HIV infection and its treatment. AIDS 5: 917–26. [DOI] [PubMed] [Google Scholar]
  • 40. Tyor WR, Glass JD, Baumrind N, McArthur JC, Griffin JW, Becker PS, Griffin DE (1993) Cytokine expression of macrophages in HIV‐1‐associated vacuolar myelopathy. Neurology 43:1002–9. [DOI] [PubMed] [Google Scholar]
  • 41. Tyor WR, Wesselingh SL, Griffin JW, McArthur JC, Griffin DE (1995) Unifying hypothesis for the pathogenesis of HIV‐associated dementia complex, vacuolar myelopathy, and sensory neuropathy. J Acquir Immune Defic Syndr Hum Retrovirol 9: 379–88. [PubMed] [Google Scholar]
  • 42. Verma A (2001) Epidemiology and clinical features of HIV‐1 associated neuropathies. J Peripher Nerv Syst 6: 8–13. [DOI] [PubMed] [Google Scholar]
  • 43. Yoshioka M, Shapshak P, Srivastava AK, Stewart RV, Nelson SJ, Bradley WG, Berger JR, Rhodes RH, Sun NC, Nakamura S (1994) Expression of HIV‐1 and interleukin‐6 in lumbosacral dorsal root ganglia of patients with AIDS. Neurology 44:1120–30. [DOI] [PubMed] [Google Scholar]
  • 44. Younger DS, Rosoklija G, Neinstedt LJ, Latov N, Jaffe IA, Hays AP (1996) HIV‐1 associated sensory neuropathy: a patient with peripheral nerve vasculitis. Muscle Nerve 19: 1364–6. [PubMed] [Google Scholar]
  • 45. Zaunders J, Carr A, McNally L, Penny R, Cooper DA (1995) Effects of primary HIV‐1 infection on subsets of CD4+ and CD8+ Tlymphocytes. AIDS 9: 561–6. [DOI] [PubMed] [Google Scholar]

Articles from Brain Pathology are provided here courtesy of Wiley

RESOURCES